6.1.20 | Mental Health Pandemic Prompts Concerns About Worsening Mental Health for Pregnant Women and New Moms
In the midst of COVID-19, pregnant women and new moms are being forced to confront unexpected challenges and possible worst-case scenarios about delivery and the postpartum period.
3.18.20 | Coronavirus SWHR Urges Inclusion of Pregnant and Lactating Women in COVID-19 Research
SWHR and other members of the Coalition to Advance Maternal Therapeutics (CAMT) urged the National Institutes of Health (NIH) and […]
10.31.19 | Research and Clinical Trials Report: Cures Act Pushes Women’s Health Research Forward
SWHR and FasterCures, a center of the Milken Institute, released a report outlining the positive changes for women’s health research from the 21st Century Cures Act.
10.16.19 | Policy The Unexpected Home for NIH’s Maternal Health Research
In the ongoing quest to ensure women’s inclusion in medical research, many stakeholders consider research involving pregnant and lactating women as the next step forward. At the NIH, these efforts are being led by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
8.20.19 | Maternal Health Searching for Solutions to the Maternal Health Crisis
Maternal mortality rates in the United States are higher than anywhere else in the developed world, and the majority of the estimated 700 pregnancy-related deaths each year are preventable.
8.8.19 | Maternal Health Examining Factors in the Maternal Health Crisis
The United States is the most dangerous country in the developed world to give birth, with an estimated 700 women dying from pregnancy-related deaths each year and 50,000 women experiencing life-threatening complications.
7.24.19 | Policy SWHR Letter in Support of PRGLAC Task Force
In a letter to the Secretary of Health and Human Services, SWHR expressed its concerns about the future status of […]
7.11.19 | Research and Clinical Trials SWHR Submits Comments to FDA on Pregnancy and Lactation Draft Guidance
SWHR submitted comments to the FDA in response to draft guidance on considerations for pregnancy safety and lactation studies.
7.8.19 | Policy SWHR Praises FDA Draft Guidance on Lactation Study Design
SWHR sent comments to the Food and Drug Administration (FDA) regarding the agency’s new draft guidance on pre- or post-market […]
7.8.19 | Policy SWHR Comments on FDA Draft Guidance on Post-Approval Pregnancy Safety Studies
SWHR provided comments to the Food and Drug Administration (FDA) on its recently released draft guidance pertaining pregnancy safety study […]
